Skip to main content

Aldeyra Therapeutics, Inc.

ALDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001341235

No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Aldeyra Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ALDX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders117115−2
Shares39.7M36.5M−3.23M (−8.1%)
Value$348.9M$146.7M−$202.2M (−58.0%)

New holders (21)

Institutions that held Aldeyra Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ALDX in Q4 2021
InstitutionSharesValue% of portfolio
Acuta Capital Partners, LLC500,000$2.00M0.84%
Walleye Capital LLC355,861$1.42M0.05%
DLD Asset Management, LP250,000$1.00M0.08%
Stonepine Capital Management, LLC200,000$800.0K0.37%
Ergoteles LLC114,795$459.0K0.02%
Engineers Gate Manager LP73,594$294.0K0.01%
Gyon Technologies Capital Management, LP51,161$205.0K0.04%
Virtu Financial LLC32,401$130.0K0.01%
Alpine Global Management, LLC22,607$90.0K0.01%
Cetera Advisor Networks LLC21,426$86.0K0.00%
HRT Financial LP18,933$75.0K0.00%
CSS LLC15,000$60.0K0.00%
ProShare Advisors LLC10,602$43.0K0.00%
Graham Capital Management, L.P.10,047$40.0K0.00%
Point72 Hong Kong Ltd7,702$31.0K0.00%
Lindbrook Capital, LLC2,541$10.0K0.00%
Stephens Consulting, LLC2,000$8.00K0.01%
Comprehensive Financial Consultants Institutional, Inc.800$3.00K0.00%
Captrust Financial Advisors500$2.00K0.00%
EverSource Wealth Advisors, LLC213$1.00K0.00%
Rockefeller Capital Management L.P.38$00.00%

Sold out (23)

Institutions that held Aldeyra Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.